-+ 0.00%
-+ 0.00%
-+ 0.00%

Qaunterix Brand, Lucent Diagnostics, Collaborates With Tempus To Integrate Blood-Based Alzheimer's Biomarker Testing Into Clinical Workflows

Benzinga·05/06/2026 12:04:22
Listen to the news

Agreement supports the identification of patients eligible for Alzheimer's disease biomarker testing through Tempus Next and enables neurologists to order LucentAD® Complete on Tempus' clinical ordering platform